Cart
sales@molnova.com
Protein Kinase C 19-36
CAS No. 113731-96-7
Protein Kinase C 19-36( —— )
Catalog No. M30202 CAS No. 113731-96-7
Protein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameProtein Kinase C 19-36
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM.
-
DescriptionProtein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorIC50: 0.18 μM (protein kise C)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number113731-96-7
-
Formula Weight2151.48
-
Molecular FormulaC93H159N35O24
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (46.48 mM)
-
SMILES——
-
Chemical NameSequence:{Arg}{Phe{Ala}{Arg}{Lys}{Gly}{Ala}{Leu}{Arg}{Gln}{Lys}{Asn}{Val}{His}{Glu}{Val}{Lys}{Asn}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Yasunari K, et al. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension. 1996 Aug;28(2):159-68.
molnova catalog
related products
-
Enzastaurin
A potent, selective, ATP-competitive PKCβ inhibitor with IC50 of 6 nM.
-
Bisindolylmaleimide ...
Bisindolylmaleimide III is a potent and selective inhibitor of protein kinase C (PKC), specifically interacting with PKCα or ribosomal S6 protein kinase 1 upon activation of these kinases.
-
D-ERYTHRO-SPHINGOSIN...
D-erythro-Sphingosine is a protein kinase C (PKC) inhibitor. D-erythro-Sphingosine (Erythrosphingosine) is also a PP2A activator.
